Gelteq Limited (GELS)
NASDAQ: GELS · Real-Time Price · USD
1.080
+0.020 (1.89%)
At close: Nov 28, 2025, 1:00 PM EST
1.100
+0.020 (1.85%)
After-hours: Nov 28, 2025, 4:39 PM EST
Gelteq Market Cap
Gelteq has a market cap or net worth of $11.57 million as of November 28, 2025. Its market cap has decreased by -45.53% in one year.
Market Cap
11.57M
Enterprise Value
14.11M
1-Year Change
-45.53%
Ranking
Category
Stock Price
$1.08
Market Cap Chart
Since the IPO on October 29, 2024, Gelteq's market cap has decreased from $37.75M to $11.57M, a decrease of -69.36%. That is a compound annual growth rate of -66.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 28, 2025 | 11.57M | -47.17% |
| Dec 31, 2024 | 21.90M | -42.00% |
| Oct 29, 2024 | 37.75M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 988.81B |
| Johnson & Johnson | 500.07B |
| AbbVie | 402.36B |
| UnitedHealth Group | 298.66B |
| AstraZeneca | 287.99B |
| Merck & Co. | 259.69B |
| Novartis AG | 249.49B |
| Abbott Laboratories | 223.51B |